Filing Details
- Accession Number:
- 0001437749-20-023003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-06 16:10:56
- Reporting Period:
- 2020-11-05
- Accepted Time:
- 2020-11-06 16:10:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1781127 | Jr Walter John Hanna | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-05 | 3,125 | $9.05 | 77,434 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-05 | 3,281 | $5.98 | 80,715 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-05 | 3,613 | $40.00 | 77,102 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-05 | 2,660 | $41.56 | 74,442 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-05 | 133 | $42.08 | 74,309 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-05 | 3,125 | $0.00 | 3,125 | $9.05 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-05 | 3,281 | $0.00 | 3,281 | $5.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,292 | 2027-03-02 | No | 4 | M | Direct | |
| 20,782 | 2028-03-01 | No | 4 | M | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.
- Represents weighted average sales price. Sale prices for the transactions range from $39.95 to $40.78. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $41.01 to $42.01. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $42.05 to $42.13. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
- The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
Billionaire Hedge Funds
